Cencora | Pharma solutions is participating in the LORENZ Converge event taking place September 14 - 16 in Frankfurt, Germany, featuring featured sessions on AI transforming scientific authoring and ICH M4Q(R2) quality guidelines.
Public source
Publisher name
Public post
We’re excited to be part of LORENZ Converge, taking place September 14 - 16 in Frankfurt, Germany, where industry leaders will come together to explore the future of reg…
Company
Cencora | Pharma solutions
At Cencora, we are investing and innovating alongside our pharma customers to unlock their product’s potential.
- Industry
- Pharmaceutical Manufacturing
- Location
- Conshohocken, US
- Company size
- 1,001–5,000 employees
About Cencora | Pharma solutions
At Cencora, we are investing and innovating alongside our pharma customers to unlock their product’s potential. Cencora is a leading global pharmaceutical solutions organization centered on improving lives. We partner with pharmaceutical innovators and care providers to facilitate access to pharmaceuticals and healthcare products. Our pharma solutions — ranging from support during drug discovery to lifecycle management — help pharmaceutical and biopharma companies of all sizes reach full product potential. Previously known as AmerisourceBergen, our 46,000+ Cencora team members power our purpose: We are united in our responsibility to create healthier futures. Cencora is ranked #11 on the Fortune 500 and #21 on the Global Fortune 500 with more than $200 billion in annual revenue. Learn more at www.Cencora.com.
See moreLatest activity
Latest activity from Cencora | Pharma solutions
8 signals
Research & Knowledge
Cencora | Pharma solutions published an article by Louis Cicchini, PhD, Senior Director of Scientific Affairs & Strategic Partnerships for CGT, and Stephen Sun, MD, VP of Pharmacovigilance, exploring why pharmacovigilance is becoming a strategic driver for cell and gene therapy success.
Research & Knowledge
Cencora | Pharma solutions reported positive Phase 3 data for a therapy targeting post-bariatric hypoglycemia.
Research & Knowledge
Cencora | Pharma solutions reported new late-stage clinical data showing an mRNA-based personalized cancer therapy delivering improved outcomes in combination with established immunotherapy.
Discover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
Adare Pharma Solutions
Adare Pharma Solutions is attending the Contract Pharma Annual Contracting & Outsourcing Conference & Tabletop Exhibition from September 24 to 25, 2026, to connect with the Adare team and learn about partner opportunities for oral solid dose success.
Presence & Recognition
Inceptua Group
Inceptua Group is attending the 18th Annual Clinical Trial Supply West Coast 2026 event on September 22 and 23 at the Hyatt Regency SF Airport.
Presence & Recognition
CorePharma®
CorePharma® is attending Contract Pharma's Contracting & Outsourcing Conference in New Brunswick, NJ from September 24 to 25.
Presence & Recognition
Transformative Pharmaceutical Solutions
Transformative Pharmaceutical Solutions is attending Partnerships with Sites 2026 in Boston at Booth 8
Presence & Recognition
RxSource